SONYA FLANAGAN: Open Payments
NPI 1083284343 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 11 payments from 7 companies in 2025. Trend: 2023 $400 · 2024 $369 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 4 | $143 |
| Axsome Therapeutics, Inc. | 2 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $96 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $86 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
Products named: NUZYRA, Auvelity, AUSTEDO XR, Tryvio, SHINGRIX, KISUNLA.
Industry payments across AL — which companies pay providers there.
